An analysis of functional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation-Reference-Cited by-同舟云学术

An analysis of functional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation

Published:2012-10-01 Issue:5 Volume:5 Page:401-404
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:Clinical Kidney Journal

Author:

Inoshita H.,Ohsawa I.,Onda K.,Tamano M.,Horikoshi S.,Ohi H.,Tomino Y.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/5/5/401/953511/sfs089.pdf

Reference18 articles.

1. Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan

2. Effect of thrombosis on complement activation and neutrophil degranulation during in vitro hemodialysis.

3. Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro

4. Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis

5. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypersensitive Reactions During Hemodialysis Treatment: What Do We Need to Know?;Seminars in Dialysis;2024-03-04

2. Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease;Frontiers in Pharmacology;2022-02-10

3. Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis;Scientific Reports;2020-12

4. Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay between Innate and Adaptive Immune Dysfunction;International Journal of Molecular Sciences;2020-05-12

5. Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?;Clinical Immunology;2019-01